HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atieh Pourbagheri-Sigaroodi Selected Research

Atieh Pourbagheri-Sigaroodi Research Topics

Disease

22Neoplasms (Cancer)
04/2022 - 01/2018
6Acute Promyelocytic Leukemia
01/2021 - 12/2018
5COVID-19
01/2022 - 11/2020
5Leukemia
11/2021 - 10/2018
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 10/2021
2Breast Neoplasms (Breast Cancer)
12/2021 - 01/2018
2Multiple Myeloma
11/2021 - 01/2019
2Hematologic Neoplasms (Hematological Malignancy)
11/2021 - 03/2019
2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)
05/2020 - 10/2018
1Acute Lung Injury
01/2022
1Melanoma (Melanoma, Malignant)
01/2022
1Neuroinflammatory Diseases
11/2021
1Lymphoma (Lymphomas)
11/2021
1Lung Injury
08/2021
1Virus Diseases (Viral Diseases)
08/2021
1Head and Neck Neoplasms (Head and Neck Cancer)
06/2021
1Squamous Cell Carcinoma of Head and Neck
01/2021
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2021
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021
1Carcinogenesis
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020
1Ovarian Neoplasms (Ovarian Cancer)
01/2020
1Inflammation (Inflammations)
01/2020

Drug/Important Bio-Agent (IBA)

6Arsenic Trioxide (Trisenox)FDA Link
10/2020 - 01/2018
3Pharmaceutical PreparationsIBA
04/2022 - 10/2020
3Phosphatidylinositols (Phosphatidylinositol)IBA
01/2021 - 12/2018
3NVP-BKM120IBA
01/2020 - 12/2018
2Immune Checkpoint InhibitorsIBA
12/2021 - 10/2021
2MicroRNAs (MicroRNA)IBA
12/2021 - 03/2019
2EnzymesIBA
11/2021 - 05/2020
2Histone Deacetylases (Histone Deacetylase)IBA
11/2021 - 05/2020
2Histone Deacetylase InhibitorsIBA
11/2021 - 05/2020
2Biomarkers (Surrogate Marker)IBA
06/2021 - 11/2020
2Pioglitazone (Actos)FDA Link
01/2021 - 01/2020
2Toll-Like Receptor 4IBA
01/2021 - 01/2020
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2021 - 01/2021
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2022
1Dual-Specificity PhosphatasesIBA
01/2022
1Complement System Proteins (Complement)IBA
01/2022
1Insulin (Novolin)FDA Link
11/2021
1CytokinesIBA
06/2021
1Antiviral Agents (Antivirals)IBA
06/2021
1Proteins (Proteins, Gene)FDA Link
05/2021
1Trypan BlueFDA Link
01/2021
1Imatinib Mesylate (Gleevec)FDA Link
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1Toll-Like Receptor AgonistsIBA
01/2021
1AutoantigensIBA
01/2021
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
01/2021
1PPAR gammaIBA
01/2021
1PanobinostatIBA
05/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
14- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA
01/2020
1ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA
01/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2020
1Telomerase (Telomerase Reverse Transcriptase)IBA
03/2019
1BIBR 1532IBA
03/2019
1carfilzomibIBA
01/2019
1Aprepitant (Emend)FDA Link
10/2018
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
10/2018
1Hormones (Hormone)IBA
01/2018
1MelatoninIBA
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1Caspase 3 (Caspase-3)IBA
01/2018
1SurvivinIBA
01/2018

Therapy/Procedure

14Therapeutics
04/2022 - 01/2018
5Immunotherapy
02/2022 - 01/2021
2Drug Therapy (Chemotherapy)
01/2022 - 12/2018
1Molecular Targeted Therapy
01/2022
1Immunomodulation
08/2021
1Radiotherapy
01/2021